Koskisen Corp (EZ8.SG)
EUR 6.72
(1.51%)
EUR 6.72
(1.51%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 35.85 Million EUR | 44.85% |
| 2022 | 69.51 Million EUR | 5.45% |
| 2021 | 62.68 Million EUR | -282.25% |
| 2020 | -4.43 Million EUR | -3595.0% |
| 2019 | -120 Thousand SEK | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q2 | 9.62 Million EUR | 58.29% |
| 2024 Q1 | -428 Thousand EUR | 453.77% |
| 2023 Q4 | -1.75 Million EUR | -71.93% |
| 2023 FY | - EUR | 44.85% |
| 2023 Q2 | -1.04 Million EUR | 35.25% |
| 2023 Q3 | -1.01 Million EUR | 2.49% |
| 2023 Q1 | -1.61 Million EUR | 40.9% |
| 2022 Q4 | -2.73 Million SEK | 7.83% |
| 2022 FY | - EUR | 5.45% |
| 2022 Q3 | -2.96 Million SEK | 20.18% |
| 2022 Q2 | -3.71 Million SEK | -8.28% |
| 2022 Q1 | -3.42 Million SEK | 0.0% |
| 2021 Q3 | -3.03 Million SEK | 3.74% |
| 2021 Q2 | -3.15 Million SEK | 0.0% |
| 2021 FY | - EUR | -282.25% |
| 2020 FY | - EUR | -3595.0% |
| 2019 FY | - SEK | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Healwell AI Inc | -16.11 Million EUR | 322.497% |